Innovative Electrophysiology Cytocybernetics specializes in advanced cellular electrophysiology tools and custom CRO services, making it a prime partner for companies developing electrophysiology-focused research and drug safety testing products.
Expanding Market Scope Recent development of CyberQ for rapid assessment of COVID-19 drugs' arrhythmogenic risks and a SBIR award targeting neuronal drug development indicate growth into niche, high-demand markets within pharma and biotech.
Early Stage Revenue With revenue estimates between 1 to 10 million dollars and a modest funding round, Cytocybernetics presents an accessible entry point for sales of laboratory equipment, assay services, or reagents tailored for electrophysiology and drug development.
Strategic Collaboration Their focus on FDA-mandated drug safety screening and custom electrophysiology solutions suggests opportunities for partnerships with pharmaceutical companies, clinical labs, and research institutions seeking specialized testing and analysis.
Technology Integration Utilizing digital tools like Statcounter, OpenResty, and YouTube, Cytocybernetics demonstrates a tech-savvy approach, presenting opportunities to offer complementary digital platforms, data analysis tools, or training services to enhance research workflows.
$500M$1B
$10M$25M
$1M$10M
$25M$50M
$100M$250MCytocybernetics uses 8 technology products and services including Statcounter, HeadJS, Lightbox, and more. Explore Cytocybernetics's tech stack below.
| Cytocybernetics Email Formats | Percentage |
| Last@cytocybernetics.com | 44% |
| First@cytocybernetics.com | 8% |
| FLast@cytocybernetics.com | 4% |
| Last@cytocybernetics.com | 44% |
Biotechnology ResearchNew York, United States11-50 Employees
Cytocybernetics specializes in cellular electrophysiology. We developed the Cybercyte, which is a very powerful, but user friendly, plug and play dynamic clamp system. We offer a complete range of CRO services, including FDA mandated drug safety screening, custom electrophysiology, custom modelling, and custom analysis.
Company Overview
Funding & FinancialsCytocybernetics has raised a total of $45K of funding over 3 rounds. Their latest funding round was raised on Oct 28, 2020 in the amount of $45K.
Cytocybernetics's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsCytocybernetics has raised a total of $45K of funding over 3 rounds. Their latest funding round was raised on Oct 28, 2020 in the amount of $45K.
Cytocybernetics's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com